Puma Biotechnology Inc - Asset Resilience Ratio

Latest as of December 2025: 31.39%

Puma Biotechnology Inc (PBYI) has an Asset Resilience Ratio of 31.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PBYI current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$67.90 Million

Cash + Short-term Investments

Total Assets

$216.30 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Puma Biotechnology Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Puma Biotechnology Inc assets under control.

Liquid Assets Composition Over Time

This chart breaks down Puma Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore PBYI strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.90 Million	31.39%
Total Liquid Assets	$67.90 Million	31.39%

Asset Resilience Insights

Very High Liquidity: Puma Biotechnology Inc maintains exceptional liquid asset reserves at 31.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Puma Biotechnology Inc Industry Peers by Asset Resilience Ratio

Compare Puma Biotechnology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Vaxcyte Inc NASDAQ:PCVX	Biotechnology	41.54%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	38.51%
Chongqing Zhifei Bio Products SHE:300122	Biotechnology	-0.08%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	2.30%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.12%

Annual Asset Resilience Ratio for Puma Biotechnology Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Puma Biotechnology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.39%	$67.89 Million	$216.30 Million	+16.51pp
2024-12-31	14.88%	$31.75 Million	$213.33 Million	+9.96pp
2023-12-31	4.93%	$11.35 Million	$230.53 Million	+2.73pp
2022-12-31	2.19%	$4.87 Million	$222.06 Million	-6.18pp
2021-12-31	8.37%	$18.98 Million	$226.59 Million	+5.06pp
2020-12-31	3.32%	$8.10 Million	$244.22 Million	-18.65pp
2019-12-31	21.97%	$51.61 Million	$234.91 Million	-0.03pp
2018-12-31	22.00%	$57.00 Million	$259.12 Million	--
2017-12-31	0.00%	$0.00	$165.53 Million	--
2016-12-31	13.85%	$35.00 Million	$252.79 Million	-63.00pp
2015-12-31	76.84%	$184.30 Million	$239.84 Million	+13.68pp
2014-12-31	63.16%	$102.80 Million	$162.76 Million	+23.97pp
2013-12-31	39.19%	$40.90 Million	$104.37 Million	--
2012-12-31	0.00%	$0.00	$151.70 Million	--
2011-12-31	0.00%	$0.00	$55.40 Million	--

pp = percentage points

About Puma Biotechnology Inc

NASDAQ:PBYI USA Biotechnology

Market Cap

$477.73 Million

Market Cap Rank

#13723 Global

#3301 in USA

Share Price

$9.39

Change (1 day)

+1.51%

52-Week Range

$4.42 - $9.69

All Time High

$132.45